AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionSpinnaker Trust
Latest Disclosed Ownership16,310 shares
Latest Disclosed Value $ 3,547,262
Spinnaker Trust reports 5.92% decrease in ownership of 4AB / AbbVie Inc.

On April 23, 2026 - Spinnaker Trust filed a 13F-HR form disclosing ownership of 16,310 shares of AbbVie Inc. (BG:4AB) valued at $3,547,262 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 17,336 shares of AbbVie Inc.. This represents a change in shares of -5.92% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-23 2026-03-31 13F AbbVie Equities 00287Y109 16,310 -1,026 -5.92 3,547 -10.45 0.1963
2026-02-10 2025-12-31 13F AbbVie Equities 00287Y109 17,336 704 4.23 3,961 2.88 0.2120
2025-11-05 2025-09-30 13F AbbVie Equities 00287Y109 16,632 0 0.00 3,851 24.72 0.2137
2025-08-04 2025-06-30 13F AbbVie Equities 00287Y109 16,632 181 1.10 3,087 -10.42 0.1857
2025-04-25 2025-03-31 13F AbbVie Equities 00287Y109 16,451 -333 -1.98 3,447 15.56 0.2250
2025-01-30 2024-12-31 13F AbbVie Equities 00287Y109 16,784 1,275 8.22 2,983 -2.61 0.1881
2024-10-31 2024-09-30 13F AbbVie Equities 00287Y109 15,509 -482 -3.01 3,063 11.67 0.1888
2024-07-31 2024-06-30 13F AbbVie Equities 00287Y109 15,991 0 0.00 2,743 -5.81 0.1756
2024-05-06 2024-03-31 13F AbbVie Equities 00287Y109 15,991 -17 -0.11 2,912 17.38 0.1880
2024-02-02 2023-12-31 13F AbbVie Equities 00287Y109 16,008 -300 -1.84 2,481 2.06 0.1687
2023-11-08 2023-09-30 13F AbbVie Equities 00287Y109 16,308 327 2.05 2,431 12.87 0.1830
2023-08-01 2023-06-30 13F AbbVie Equities 00287Y109 15,981 210 1.33 2,153 -14.33 0.1564
2023-04-13 2023-03-31 13F AbbVie Equities 00287Y109 15,771 -46 -0.29 2,513 125,550.00 0.1905
2023-02-02 2022-12-31 13F AbbVie Equities 00287Y109 15,817 -250 -1.56 3 -99.91 0.1992
2022-10-28 2022-09-30 13F AbbVie Equities 00287Y109 16,067 -50 -0.31 2,156 -12.64 0.1788
2022-07-25 2022-06-30 13F AbbVie Equities 00287Y109 16,117 -38 -0.24 2,468 -5.77 0.1904
2022-05-02 2022-03-31 13F AbbVie Equities 00287Y109 16,155 -352 -2.13 2,619 17.18 0.1766
2022-01-31 2021-12-31 13F AbbVie Equities 00287Y109 16,507 1,000 6.45 2,235 33.59 0.1432
2021-11-02 2021-09-30 13F AbbVie Equities 00287Y109 15,507 435 2.89 1,673 -1.47 0.1164
2021-08-09 2021-06-30 13F AbbVie Equities 00287Y109 15,072 -19 -0.13 1,698 3.98 0.1183
2021-04-30 2021-03-31 13F AbbVie Equities 00287Y109 15,091 445 3.04 1,633 4.08 0.1225
2021-01-26 2020-12-31 13F AbbVie Equities 00287Y109 14,646 0 0.00 1,569 22.39 0.1251
2020-10-27 2020-09-30 13F AbbVie Equities 00287Y109 14,646 277 1.93 1,282 -9.08 0.1136
2020-07-21 2020-06-30 13F AbbVie Equities 00287Y109 14,369 -161 -1.11 1,410 27.37 0.1336
2020-05-05 2020-03-31 13F AbbVie Equities 00287Y109 14,530 -349 -2.35 1,107 -15.95 0.1217
2020-02-05 2019-12-31 13F AbbVie Equities 00287Y109 14,879 -1,903 -11.34 1,317 3.70 0.1203
2019-11-12 2019-09-30 13F AbbVie Equities 00287Y109 16,782 1,050 6.67 1,270 11.01 0.1253
2019-07-11 2019-06-30 13F AbbVie Equities 00287Y109 15,732 95 0.61 1,144 -9.21 0.1149
2019-04-29 2019-03-31 13F AbbVie Equities 00287Y109 15,637 0 0.00 1,260 -12.56 0.1266
2019-02-04 2018-12-31 13F AbbVie Equities 00287Y109 15,637 8,645 123.64 1,441 118.00 0.1637
2018-10-23 2018-09-30 13F AbbVie Equities 00287Y109 6,992 -1,050 -13.06 661 -11.28 0.0653
2018-08-02 2018-06-30 13F AbbVie Equities 00287Y109 8,042 0 0.00 745 -2.10 0.0794
2018-05-10 2018-03-31 13F AbbVie Equities 00287Y109 8,042 2,172 37.00 761 34.22 0.0828
2018-02-09 2017-12-31 13F AbbVie Equities 00287Y109 5,870 1,250 27.06 567 38.29 0.0658
2017-10-26 2017-09-30 13F AbbVie Equities 00287Y109 4,620 -10 -0.22 410 22.02 0.0512
2017-07-27 2017-06-30 13F AbbVie Com 00287Y109 4,630 1,374 42.20 336 58.49 0.0420
2017-05-10 2017-03-31 13F AbbVie Com 00287Y109 3,256 3,256 212 0.0275
2016-05-05 2016-03-31 13F AbbVie Com 00287Y109 0 -3,444 -100.00 0 -100.00
2016-01-29 2015-12-31 13F AbbVie Com 00287Y109 3,444 -400 -10.41 204 -2.39 0.0291
2015-11-06 2015-09-30 13F AbbVie Com 00287Y109 3,844 0 0.00 209 -18.99 0.0320
2015-08-05 2015-06-30 13F AbbVie Com 00287Y109 3,844 3,844 258 0.0385
2015-04-17 2015-03-31 13F AbbVie Com 00287Y109 0 -3,252 -100.00 0 -100.00
2015-01-22 2014-12-31 13F AbbVie Com 00287Y109 3,252 -600 -15.58 213 -4.05 0.0316
2014-11-03 2014-09-30 13F AbbVie Com 00287Y109 3,852 -2,289 -37.27 222 -29.75 0.0358
2014-04-23 2014-03-31 13F AbbVie Com 00287Y109 6,141 0 0.00 316 -2.47 0.0520
2014-01-24 2013-12-31 13F AbbVie Com 00287Y109 6,141 1,239 25.28 324 47.95 0.0540
2013-10-28 2013-09-30 13F AbbVie Com 00287Y109 4,902 4,902 219 0.0397
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.